What is already known? CGM is underutilized in low- and middle-income countries (LMICs). Earlier results from the CAPT1D study suggest that CGM can rapidly improve glycaemic parameters in Rwandans with type 1 diabetes. What has this study found? Improvements in HbA1c and time in range were sustained for up to 2 years with minimal supervision; however, time below range and glycaemic variability increased. Participants were satisfied with the technology and used it consistently.
John Welsh
London
As seen in:
Forbes,
The Guardian,
Wiley Online Library,
Yahoo Canada,
arXiv,
KYW-TV (Philadelphia, PA),
Memory Studies,
WWJ-TV (Detroit, MI),
Harvard Business Review,
The Minnesota Star Tribune
and
Covers:
I write about leaders, European rather than U.S., diverse by gender, ethnicity, race, neural and age.
leaders’ coach
Get in touch with John
Contact John, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
John Welsh’s Biography
Read Full Bio →I am an executive coach, a contributor to Forbes.com, an advisor to the National Business Awards and a Tech London Advocate. I spent 23 years in a FTSE 250 global media company, first as an award-winning editor of magazines then a digital transformation and business leader, both in the US and Europe, and an EMEA division board member.